Stocks Comparison
Bio-Rad Laboratories vs Mettler Toledo International Inc/: revenue, profit, margins and growth compared
Bio-Rad Laboratories brought in $2.6B of revenue in fiscal 2025, Mettler Toledo International Inc/ $4B in fiscal 2025. Revenue changed by +0.7% at Bio-Rad Laboratories and +4.0% at Mettler Toledo International Inc/ on the year before, so Mettler Toledo International Inc/ grew faster. Bio-Rad Laboratories kept 29.4% of its revenue as net profit, Mettler Toledo International Inc/ 21.6%. Free cash flow was $374.6M at Bio-Rad Laboratories and $848.6M at Mettler Toledo International Inc/.
Side by side, latest fiscal year
| BIO | MTD | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $2.6B | $4B |
| Revenue growth | +0.7% | +4.0% |
| Net income | $759.9M | $869.2M |
| Net margin | 29.4% | 21.6% |
| Free cash flow | $374.6M | $848.6M |
| Free cash flow margin | 14.5% | 21.1% |
| Earnings per share (diluted) | $27.85 | $42.05 |
| Cash | $529.8M | $66.9M |
| Debt | $1.2B | $2.1B |
| Price to earnings | 13.7 | 36.0 |
| Market value | $10.2B | $30.3B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #194 of 451 · Industrials | #140 of 451 · Industrials |
Over the years
Questions about Bio-Rad Laboratories and Mettler Toledo International Inc/
Which is bigger by revenue, Bio-Rad Laboratories or Mettler Toledo International Inc/?
Mettler Toledo International Inc/ is bigger by revenue: $4B in fiscal 2025, against $2.6B for Bio-Rad Laboratories in fiscal 2025.
Which keeps more of its revenue as profit, Bio-Rad Laboratories or Mettler Toledo International Inc/?
Bio-Rad Laboratories had a net margin of 29.4% in fiscal 2025; Mettler Toledo International Inc/ had 21.6% in fiscal 2025.
Which grew revenue faster, Bio-Rad Laboratories or Mettler Toledo International Inc/?
In their latest fiscal years revenue changed by +0.7% at Bio-Rad Laboratories and +4.0% at Mettler Toledo International Inc/.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.